Matthew Baker
17Patents
6h-index
23Co-inventors
62Inventor score
Filing activity: Feb 18, 2002 → Mar 11, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7670595B2 | Fc-interferon-beta fusion proteins | Chemistry; Metallurgy | 41 | Active |
| US7456257B2 | Fusion proteins of interferon alpha muteins with improved properties | Chemistry; Metallurgy | 17 | Expired |
| US7189830B2 | Anti-KSA/IL-2 fusion proteins with reduced immunogenicity | Chemistry; Metallurgy | 14 | Expired |
| US7524502B2 | Modified anti-TNF alpha antibody | Chemistry; Metallurgy | 12 | Expired |
| US8470314B2 | Modified toxins | Chemistry; Metallurgy | 12 | Active |
| US10059750B2 | Modified toxins | Chemistry; Metallurgy | 9 | Active |
| US7754853B2 | TNF alpha-binding polypeptide compositions and methods | Chemistry; Metallurgy | 6 | Active |
| US7339031B2 | Modified bouganin proteins, cytotoxins and methods and uses thereof | Chemistry; Metallurgy | 5 | Expired |
| US7750136B2 | Modified bouganin proteins, cytotoxins and methods and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US8252897B2 | Modified toxins | Human Necessities | 4 | Active |
| US7381795B2 | Modified interferon beta with reduced immunogenicity | Human Necessities | 4 | Expired |
| US8557232B2 | Stabilization of Fc-interferon-beta fusion proteins | Chemistry; Metallurgy | 3 | Active |
| US8716234B2 | Cytotoxins comprising modified bouganin toxin for the treatment of cancer | Chemistry; Metallurgy | 1 | Active |
| US7615217B2 | Artificial proteins with reduced immunogenicity | Chemistry; Metallurgy | 1 | Active |
| US7425533B2 | Modified hirudin proteins and T-cell epitopes in hirudin | Chemistry; Metallurgy | 1 | Expired |
| US7541439B2 | Thrombopoietin proteins with improved properties | Chemistry; Metallurgy | 0 | Expired |
| US7615615B2 | Modified interferon beta with reduced immunogenicity | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.